The aim of this study was to measure the effect of moderate and intensive lipid-lowering treatment with rosuvastatin on the endothelial function.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
87
Rosuvastatin 5mg/day
Rosuvastatin 40mg/day
Department of Cardiology, Odense University Hospital
Odense, Fuenen, Denmark
The change from baseline in endothelium-dependent flow mediated vasodilatation of the brachial artery.
Time frame: One year
The change from baseline in endothelium independent flow mediated vasodilatation of the brachial artery
Time frame: One Year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.